Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dosing for treatment with anti-CD20/anti-CD3 bispecific antibodies

Dosing for treatment with anti-CD20/anti-CD3 bispecific antibodies

US Patent 12351643 · Granted Jul 8, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Subcutaneous dosing of anti-CD20/anti-CD3 bispecific antibodies2025
Subcutaneous dosing of anti-CD20/anti-CD3 bispecific antibodies2025
Methods for treatment of CD20-positive proliferative disorder with mosunetuzumab2025
Methods and compositions for treating CD33+ cancers and improving in vivo persis2024
Dosing for treatment with anti-CD20/anti-CD3 bispecific antibodies2022
Antibody buffering of a ligand in vivo2015
Dispersions of microemulsions in hydrogels for drug delivery2011